7
Views
19
CrossRef citations to date
0
Altmetric
Original Articles

Effect of dose on the inhibition of carcinogenesis/mutagenesis by aroclor 1254 in rainbow trout fed aflatoxin B1

, , &
Pages 649-657 | Received 13 Aug 1983, Accepted 12 Oct 1983, Published online: 20 Oct 2009
 

Abstract

Prior studies have shown that Aroclor 1254 (PCB) differentially alters the incidence of aflatoxin B 1 (AFB 1 ) induced hepatocellular carcinomas in trout, depending upon the time of PCB administration relative to AFB 1 exposure (Shelton et al., 1983). When fed simultaneously with AFB 1 , PCB inhibits carcinoma incidence. We investigated the effect of AFB 1 and PCB dose on this inhibition. Duplicate tanks of 100 rainbow trout were fed AFB 1 at concentrations of 1, 4, or 8 ppb, either with or without the addition of 50 ppm PCB. Other groups were fed 4 ppb AFB 1 + 5 ppm PCB, 50 ppm PCB alone, or control diet alone. After 9 and 12 mo, 40 and 60 fish per tank, respectively, were sampled to determine the incidence of liver tumors. The results show a parallel Inhibition of the AFB 1 ‐tumor dose‐response curve by the presence of 50 ppm PCB. Fish fed 4 ppb AFB 1 + 5 ppm PCB showed slight inhibition in response when compared with 4ppb AFB 1 alone. Also, livers from fish fed 50 ppm PCB were used to prepare S20 for use in the Salmonella mutagenesis assay. These livers were less efficienct in converting AFB 1 to a mutagen, when compared to control S20. The AFB 1 ‐mutagenesis dose‐response curve was again shifted parallel to the right of the curve generated using control S20. These results suggest that the inhibitory action is at least partly at the level of carcinogen activation. The finding of parallel, as opposed to proportional, inhibition with varying carcinogen exposure for certain classes of inhibitors may have important implications for inhibition of environmental carcinogenesis at low levels of carcinogen exposure.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.